Geode Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.2M | Buy |
2,049,350
+26,365
| +1% | +$247K | ﹤0.01% | 1979 |
|
|
2025
Q1 | $24.9M | Buy |
2,022,985
+49,869
| +3% | +$613K | ﹤0.01% | 1784 |
|
|
2024
Q4 | $26.1M | Sell |
1,973,116
-3,966
| -0.2% | -$52.4K | ﹤0.01% | 1817 |
|
|
2024
Q3 | $38.1M | Buy |
1,977,082
+66,459
| +3% | +$1.28M | ﹤0.01% | 1608 |
|
|
2024
Q2 | $39.2M | Buy |
1,910,623
+132,075
| +7% | +$2.71M | ﹤0.01% | 1518 |
|
|
2024
Q1 | $42.3M | Buy |
1,778,548
+243,493
| +16% | +$5.8M | ﹤0.01% | 1468 |
|
|
2023
Q4 | $33.2M | Buy |
1,535,055
+174,135
| +13% | +$3.76M | ﹤0.01% | 1603 |
|
|
2023
Q3 | $19.8M | Buy |
1,360,920
+39,817
| +3% | +$578K | ﹤0.01% | 1830 |
|
|
2023
Q2 | $27.7M | Buy |
1,321,103
+93,502
| +8% | +$1.96M | ﹤0.01% | 1640 |
|
|
2023
Q1 | $25.9M | Buy |
1,227,601
+126,572
| +11% | +$2.67M | ﹤0.01% | 1630 |
|
|
2022
Q4 | $28M | Buy |
1,101,029
+132,900
| +14% | +$3.38M | ﹤0.01% | 1546 |
|
|
2022
Q3 | $23.3M | Buy |
968,129
+60,273
| +7% | +$1.45M | ﹤0.01% | 1625 |
|
|
2022
Q2 | $17.5M | Buy |
907,856
+52,441
| +6% | +$1.01M | ﹤0.01% | 1856 |
|
|
2022
Q1 | $14.9M | Buy |
855,415
+90,788
| +12% | +$1.58M | ﹤0.01% | 2083 |
|
|
2021
Q4 | $16.7M | Buy |
764,627
+31,407
| +4% | +$687K | ﹤0.01% | 2080 |
|
|
2021
Q3 | $14M | Buy |
733,220
+26,278
| +4% | +$502K | ﹤0.01% | 2210 |
|
|
2021
Q2 | $12.1M | Buy |
706,942
+140,019
| +25% | +$2.4M | ﹤0.01% | 2323 |
|
|
2021
Q1 | $12.7M | Buy |
566,923
+103,747
| +22% | +$2.32M | ﹤0.01% | 2199 |
|
|
2020
Q4 | $10.3M | Buy |
463,176
+51,163
| +12% | +$1.14M | ﹤0.01% | 2158 |
|
|
2020
Q3 | $6.08M | Sell |
412,013
-2,677
| -0.6% | -$39.5K | ﹤0.01% | 2278 |
|
|
2020
Q2 | $6.15M | Buy |
414,690
+81,432
| +24% | +$1.21M | ﹤0.01% | 2207 |
|
|
2020
Q1 | $3.66M | Buy |
333,258
+33,057
| +11% | +$363K | ﹤0.01% | 2327 |
|
|
2019
Q4 | $2.64M | Buy |
300,201
+13,963
| +5% | +$123K | ﹤0.01% | 2839 |
|
|
2019
Q3 | $2.14M | Buy |
286,238
+17,681
| +7% | +$132K | ﹤0.01% | 2908 |
|
|
2019
Q2 | $2.5M | Buy |
268,557
+70,951
| +36% | +$660K | ﹤0.01% | 2804 |
|
|
2019
Q1 | $1.04M | Buy |
197,606
+17,407
| +10% | +$91.3K | ﹤0.01% | 3148 |
|
|
2018
Q4 | $801K | Buy |
180,199
+6,768
| +4% | +$30.1K | ﹤0.01% | 3198 |
|
|
2018
Q3 | $1.4M | Buy |
173,431
+5,040
| +3% | +$40.7K | ﹤0.01% | 3078 |
|
|
2018
Q2 | $1.18M | Buy |
168,391
+13,835
| +9% | +$97.1K | ﹤0.01% | 3114 |
|
|
2018
Q1 | $2.2M | Buy |
154,556
+1,073
| +0.7% | +$15.3K | ﹤0.01% | 2706 |
|
|
2017
Q4 | $1.34M | Buy |
153,483
+22,803
| +17% | +$200K | ﹤0.01% | 2975 |
|
|
2017
Q3 | $1.53M | Buy |
130,680
+4,681
| +4% | +$54.7K | ﹤0.01% | 2894 |
|
|
2017
Q2 | $1.76M | Buy |
125,999
+27,037
| +27% | +$378K | ﹤0.01% | 2809 |
|
|
2017
Q1 | $1.36M | Buy |
98,962
+9,410
| +11% | +$129K | ﹤0.01% | 2866 |
|
|
2016
Q4 | $642K | Buy |
89,552
+2,517
| +3% | +$18K | ﹤0.01% | 3183 |
|
|
2016
Q3 | $1.32M | Buy |
87,035
+57,056
| +190% | +$865K | ﹤0.01% | 2797 |
|
|
2016
Q2 | $295K | Buy |
+29,979
| New | +$295K | ﹤0.01% | 3435 |
|